A recently published global genome study that used the data-intensive Gordon supercomputer at the San Diego Supercomputer at the University of California, San Diego, has researchers rethinking how avian lineages diverged after the extinction of the dinosaurs.
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer’s disease (AD). The study, published March 12 in Cell Stem Cell, is based on experiments with cultured neurons derived from adult stem cells.
Jamila K. Stockman, PhD, MPH, assistant professor of medicine and global public health at the University of California, San Diego School of Medicine has been selected to receive the Linda E. Saltzman New Investigator Award.
Attendees at the CENIC 2015 Annual Conference, “Shaking Things Up,” will be introduced to the Pacific Research Platform, a cutting-edge research infrastructure that will link together the Science DMZs of dozens of top research institutions via three advanced networks: CENIC’s California Research & Education Network (CalREN), the Department of Energy’s Energy Science Network (ESnet), and Pacific Wave.
The 2016 edition of U.S. News & World Report’s Best Graduate Schools guidebook, released today, highly ranks the University of California, San Diego’s professional schools and programs in engineering and medicine. The campus’s academic Ph.D. programs in the sciences, social sciences and humanities earn top marks in the book as well.
Researchers at the Veterans Affairs San Diego Healthcare System and University of California, San Diego School of Medicine, with colleagues in New York and the United Kingdom, have identified genetic markers, derived from blood samples that are linked to post-traumatic stress disorder (PTSD). The markers are associated with gene networks that regulate innate immune function and interferon signaling.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
